ドラッグデリバリー技術の世界市場：投与経路別、治療領域別、エンドユーザー別、地域別

世界のドラッグデリバリー技術の市場規模は、2025年には497億9,000万米ドルと推定され、2032年には1,164億9,000万米ドルに達すると予測され、2025年～2032年のCAGRは12.9%で成長する見込みです。

図.ドラッグデリバリー技術市場シェア（%）、2025年、地域別

ドラッグデリバリーとは、必要な治療効果を安全に得るために、医薬化合物を体内で輸送するためのアプローチ、製剤、技術、システムを指します。薬剤分子を分解から保護し、放出速度を制御することで、有効性と安全性を向上させるため、さまざまなドラッグデリバリー技術が開発されています。免疫療法、遺伝子治療、精密医療などの分野における進歩が、より効果的なドラッグデリバリー方法の需要を促進しています。同市場では、リポソーム、マイクロスフェア、ナノキャリアなど、体内の標的部位に効率的に薬物を送達できる新しい薬物キャリアシステムの技術革新が見られます。さらに、慢性疾患の有病率の上昇、生物製剤市場の成長、この分野における主要企業の研究開発投資の増加は、予測期間中の市場成長を促進すると予想される主な要因の一部です。

市場力学：

世界のドラッグデリバリー技術市場は、主にがん、糖尿病、心血管疾患などの慢性疾患の世界の有病率の上昇によって牽引されています。2023年9月、世界保健機関（WHO）によると、2020年に世界で報告された死亡者数の約60%を慢性疾患が占めています。ドラッグデリバリーシステムは、医薬品治療の有効性と慢性患者の臨床転帰を改善するのに役立ちます。さらに、生物製剤市場の成長により、高分子の生物治療薬に対する高度なドラッグデリバリーアプローチの機会も生まれています。しかし、新規ドラッグデリバリーシステムの研究開発と製造に関連する高コストが、予測期間中の市場成長の妨げになる可能性があります。ナノメディシン、注射薬物送達、3Dプリントの分野における進歩は、市場拡大の有利な機会を提供します。

本調査の主な特徴

本レポートでは、世界のドラッグデリバリー技術市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模とCAGR%を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界のドラッグデリバリー技術市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

主な企業は、Johnson &Johnson Pvt. Ltd.、Pfizer Inc.、Novartis AG、Merck &Co., Inc.、GlaxoSmithKline PLC、Sanofi S.A.、Bayer AG、Abbott Laboratories、3M Company、Antares Pharma、Alkermes PLC、Vectura Group PLC、Generex Biotechnology Corporation、F. Hoffmann-La Roche Ltd.、Medtronic PLCなどです。

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界のドラッグデリバリー技術市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界のドラッグデリバリー技術市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 促進要因
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• ポーターの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界のドラッグデリバリー技術市場：投与経路別（2020年～2032年）

• 経口
• 非経口
• 鼻腔内ドラッグデリバリー
• 眼科ドラッグデリバリー
• 局所/経皮

第5章 世界のドラッグデリバリー技術市場：治療領域別（2020年～2032年）

• 腫瘍学
• 心臓病学
• 神経学
• 免疫学
• リウマチ学
• 糖尿病
• その他（感染症等）

第6章 世界のドラッグデリバリー技術市場：エンドユーザー別（2020年～2032年）

• 外来外科クリニック
• 診断センター
• 病院
• 在宅ケア環境
• その他

第7章 世界のドラッグデリバリー技術市場：地域別（2020年～2032年）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第8章 競合情勢

• Johnson & Johnson Pvt. Ltd.
• Pfizer Inc.
• Novartis AG
• Merck & Co., Inc.
• GlaxoSmithKline PLC
• Sanofi S.A.
• Bayer AG
• Abbott Laboratories
• 3M Company
• Antares Pharma
• Alkermes PLC
• Vectura Group PLC
• Generex Biotechnology Corporation
• F. Hoffmann-La Roche Ltd.
• Medtronic PLC

第9章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• Coherent Opportunity Map（COM）

第10章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global Drug Delivery Technologies Market is estimated to be valued at USD 49.79 Bn in 2025 and is expected to reach USD 116.49 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2032.

Figure. Drug Delivery Technologies Market Share (%), By Region 2025

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Various drug delivery technologies have been developed to improve efficacy and safety of drug molecules by protecting them from degradation and controlling their release rates. Advancements in areas such as immunotherapy, gene therapy, and precision medicine have fueled the demand for more effective drug delivery methods. The market has witnessed innovation of novel drug carrier systems such as liposomes, microspheres, nanocarriers, and other that can efficiently deliver drugs to targeted sites in the body. Furthermore, rising prevalence of chronic diseases, growth of biologics market, and increased R&D investments from key players in this field are some of the key factors expected to drive market growth during the forecast period.

Market Dynamics:

Global drug delivery technologies market is primarily driven by the rising global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In September 2023, according to the World Health Organization (WHO), chronic diseases accounted for approximately 60% of all reported deaths in the world in 2020. Drug delivery systems help improve the efficacy of pharmaceutical therapies and clinical outcomes of chronic patients. Furthermore, growth of the biologics market has also created opportunities for advanced drug delivery approaches for large molecule biotherapeutics. However, high costs associated with the R&D and manufacturing of novel drug delivery systems may hinder the market growth during the forecast period. Advancements in areas of nanomedicine, injectable drug delivery, and 3D printing offer lucrative opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global drug delivery technologies market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug delivery technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson Pvt. Ltd., Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline PLC, Sanofi S.A., Bayer AG, Abbott Laboratories, 3M Company, Antares Pharma, Alkermes PLC, Vectura Group PLC, Generex Biotechnology Corporation, F. Hoffmann-La Roche Ltd., and Medtronic PLC

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug delivery technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery technologies market

Market Segmentation

• Route of Administration Insights (Revenue, USD Bn, 2019 - 2032)
  • Oral
  • Parenteral
  • Intramuscular
  • Intravenous
  • Intra-Arterial
  • Subcutaneous
  • Nasal Drug Delivery
  • Ocular Drug Delivery
  • Topical/Transdermal
• Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2032)
  • Oncology
  • Cardiology
  • Neurology
  • Immunology
  • Rheumatology
  • Diabetes
  • Others (Infectious Diseases, etc.)
• End User Insights (Revenue, USD Bn, 2019 - 2032)
  • Ambulatory Surgical Clinics
  • Diagnostic Centers
  • Hospitals
  • Homecare Settings
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson Pvt. Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Sanofi S.A.
  • Bayer AG
  • Abbott Laboratories
  • 3M Company
  • Antares Pharma
  • Alkermes PLC
  • Vectura Group PLC
  • Generex Biotechnology Corporation
  • F. Hoffmann-La Roche Ltd.
  • Medtronic PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Drug Delivery Technologies Market, By Route of Administration
  • Global Drug Delivery Technologies Market, By Therapeutic Area
  • Global Drug Delivery Technologies Market, By End User
  • Global Drug Delivery Technologies Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Drug Delivery Technologies Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intramuscular
  • Intravenous
  • Intra-Arterial
  • Subcutaneous
• Nasal Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ocular Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Topical/Transdermal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Drug Delivery Technologies Market, By Therapeutic Area, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rheumatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Infectious Diseases, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Drug Delivery Technologies Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Ambulatory Surgical Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Drug Delivery Technologies Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Route of Administration , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Route of Administration , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Route of Administration , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Johnson & Johnson Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
• 3M Company
• Antares Pharma
• Alkermes PLC
• Vectura Group PLC
• Generex Biotechnology Corporation
• F. Hoffmann-La Roche Ltd.
• Medtronic PLC

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us